In EUR m
|
Q3 2023
|
Q3 2022
|
9M 2023
|
9M 2022
|
Revenue
|
483.6
|
436.3
|
1,348.3
|
1,246.3
|
EBITDA (adjusted)
|
147.5
|
133.6
|
374.6
|
353.9
|
Exceptional items
|
0.3
|
-2.7
|
-4.0
|
5.4
|
EBITDA
|
147.7
|
130.9
|
370.7
|
359.3
|
Amortization, depreciation and impairment
|
-78.6
|
-73.3
|
-231.2
|
-219.6
|
thereof attributable to purchase price allocations and impairment losses
|
|
|
|
|
EBIT
|
-4.5
|
-6.8
|
-14.3
|
-20.3
|
Net finance income/costs
|
69.2
|
57.6
|
139.4
|
139.7
|
EBT
|
-19.8
|
-5.4
|
-48.2
|
-17.7
|
Taxes
|
49.4
|
52.2
|
91.2
|
122.0
|
Consolidated profit or loss for the period
|
-14.2
|
-13.0
|
-25.7
|
-29.1
|
Adjusted consolidated profit or loss for the period
|
35.2
|
39.1
|
65.5
|
92.9
|
Free cash flow (before M&A transactions)
|
38.5
|
46.3
|
78.5
|
104.2
|
|
50.2
|
32.2
|
127.4
|
115.9
|
Net debt (Sep. 30/Dec. 31)
|
|
|
860.9
|
718.0
|